Press Room

Guy Villax won the EY award "Entrepreneur of the Year" in Portugal and he will represent Portugal at the EY World "Entrepreneur of the Year", next June. Upon receiving the award, Guy Villax stated that this is an important distinction for Hovione, above all it recognizes the team that built this company over the last 25 years, and he thanked and congratulated all Hovione Team Members for the success. Guy Villax also said that we are a company with 60+ years, with strong values, with innovation at its core, but to endure into the future it needs to be able to constantly re-invent itself: “A company that does not move forward, dies. You have to constantly look for opportunities, look for ways to stay ahead of the competition, and innovation is central to success”.   The EY Award "Entrepreneur Of The Year" was created in the USA in 1986 to recognize and encourage Entrepreneurs that are marked by creativity that invest themselves in a corporate project with vision and achieve success. In Portugal, the EY “Entrepreneur Of The Year” is in its 8th edition.   Votes are open for the election of EY World Entrepreneur Of The Year™ 2021: Cast your vote here          

News
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs

Guy Villax wins EY Award “Entrepreneur of the Year”

Apr 12, 2021

Today we are celebrating another anniversary, our 62nd. Hovione was established in Portugal in 1959 by Ivan Villax with his wife, Diane Villax, and two other Hungarian refugees: Nicholas de Horthy and Andrew Onody, the first two letters of the three founders’ names: HO, VI and ON were used to create the name Hovione.  Working initially out of the basement of the Villax family home in Lisbon, success soon followed. Today, we have a global footprint, employing over 2,000 people of 34 nationalities, working in 9 locations from 3 continents. Hovione remains a privately-owned, family business.   Learn more about our 62 years of history    

News
April 8, 2021

Today we celebrate our 62nd Anniversary

Apr 08, 2021

Today, together with over 50 other businesses in Ireland, we have committed to new climate action goals.  As part of Hovione’s commitment to climate action, we are proud to have signed up to the new Business in the Community Ireland Low Carbon Pledge. And we commit to set our carbon emissions reduction targets based on science by 2024 across our entire business and supply chain. The Low Carbon Pledge is the first dedicated pledge generated by Irish businesses to set industry standards on sustainability and reduce carbon emissions. Originally launched in 2018, the Pledge has now evolved and calls on all Irish businesses to work towards setting science-based emission reduction targets by 2024. This is a landmark day for Hovione Cork as we continue to work towards low carbon operations and commit to new climate action goals.   Find more about Sustainability at Hovione      

News
Business Action on climate

The Low Carbon Pledge

Mar 24, 2021

  Dear representatives of the Commission, Dear Ministers, Ladies and Gentlemen, Good-Morning It is a privilege for me to address you.   Dear Pedro thank you for giving me this opportunity.   I have been fortunate to have a front row seat watching the Pharmaceutical Industry since I was born, that was 60 years ago. Hovione was founded by my father, a Hungarian refugee, in the basement of our home in Lisbon. Often as children we could not go into the garden because a bromination was going on a l’air libre for safety reasons! My first job in the family business, aged 24, was selling active ingredients made in Portugal to Indian firms in Bombay, Madras, Delhi and Goa.   I will start by telling you about the successes of our industry and end with our failures as these are the ones we need to collectively tackle.   10 years after the HIV virus was discovered in Paris and Washington, American companies invented the protease inhibitors that would treat this horrible disease. But who made these complex molecules industrially possible then were exclusively European companies.   In the last decade several cures for Hepatitis C were discovered. Over 4 million patients have been cured and ¾ of those with pills made with a Hovione process with product that came out of our plants in Portugal and Ireland.   It is also important to acknowledge the complexity of the manufacturing processes and the extreme specialization that each step requires. Remdesivir, one of 3 approved therapies for Covid-19 needs factories in two continents just to make the active ingredient, but it won’t work without an enabling excipient called Captisol® that Hovione makes exclusively. To face the pandemic’s tremendous demand we are now making per month what we usually made per year.   Europe has 600+ plants that have the science, the technology, the know-how and the capacity to be the workhorse of innovative medicines for global supply. For most of us it has been some time that we have stopped focusing on serving the generics industry of our home market, Europe. Hovione has not supplied one kilo of a generic API to Germany for 15 years because one cent of difference means the Indian product is preferred. Had we not exported to the USA and served innovators and generics there we would be bankrupt, or weak and unable to invest in R&D and new technology.   The beauty of the pharma ecosystem is that the very high prices of patented products pay for the R&D and the risk, but as soon as the patents expire the best science can be had for a few cents per pill. Innovative drugs, under patent, and the large multinationals are today a minority volume player – over 80% of prescriptions are filled by generics.   Today the EU is not in control of its generic medicines – we face frequent shortages and a geostrategic fundamental dependence for APIs and precursors from India and China – where serious accidents, government policies and market failures make us vulnerable.    We have ended up in this untenable situation due to 1) the unbridled market forces of globalization and 2) 30 years of EU regulations that failed to consider that pharma is an intensely globalized and highly competitive industry.   Europe was once the cradle of pharmaceuticals. In the 50s any American that wanted to study chemistry had to learn to speak German as all good text books were written in German. We have faced a 30 year decline – today in the top 10 largest generic firms in the world only 1 is European.     As an industry we survived by moving away from intermediates and generic APIs – including the essential ones – and focusing on high value innovative products. The world is competitive and if the climate in Europe in unfavorable to certain segments, factories move – it is that simple.   Nobody saw the unfolding of this radical structural transformation. Nobody heard Industry’s calls for levelling the playing field.     In 2004 the EU API industry founded EFCG, the European Fine Chemicals Group, a member of CEFIC, to level the playing field, this need remains.    In my first trip to Brussels to flag the growing risk to patients and the lack of level playing field, in 2005, I was met with bemusement, étonnement and some sarcasm. In 2007 I testified at a hearing of a sub-committee of the US congress in connection with the risks to patient from imported APIs. I went public and frequently said and wrote that EU Regulators inspected on proximity not risk. The contaminated heparin tragedy that killed over 150 patients occurred in 2008. By 2011 our advocacy work resulted in the Falsified Medicines Directive, too little, too late.    Today price pressure has driven the European Generics supply chain to, in 74% of cases, buy from low-cost countries. These production locations have low regulatory oversight therefore present higher risk to patient, often cause environmental damage and antimicrobial resistance because of poor control over wastes, and have a high frequency of deadly accidents – the EU industry cannot compete with such low standard, low cost operations.    In summary in the last 30 years a large part of the EU API and intermediates industry disappeared to the benefit of its competitors. Certain key technologies (eg fermentation, nitration, halogenation) almost disappeared from Europe. This represents a damaging loss of critical mass, as these technologies act as platforms that allow the production of many different APIs.  Fermentation is key to making many antibiotics. Without fermentation Europe is now totally vulnerable and dependent on supplies from Asia/China.   To reduce this dependence and to ensure the resilience of the medicines supply chains on the long term, the only solution is to rely on the robust, reliable, competitive and sustainable manufacturing capabilities we still have in Europe.   So what are Industry’s proposals in this regard?   First, we must support the existing European manufacturers of APIs and intermediates in the on-shoring of technologies that will guarantee the supply of the essential medicines. Dual sourcing of the essential medicines must be a cornerstone of our policies.   Second, level the playing field with other world regions to ensure that import and purchase requires not only verified compliance with GMPs, but also demands process safety, respect for the environment and an absolutely reliable supply chain. Linking the purchase of critical supplies to the sole criteria of price cannot be a sustainable supply strategy.   Third, we need a long-term EU industrial policy that can accelerate sustainable Research, Development and industrialization of innovative and green technologies, as well as manufacturing capacities within the EU territory.   Fourth, regulatory centralization, transparency and flexibility. EMA must be given more clout. We need a central record of EU shortages.  EMA must know the complete supply chain mapping of each medicine, so it can act. EMA should turn into a compliance matter the good example of the Swedish regulator that considers environmental aspects when granting permits and approving products and APIs.   We are optimistic that this straightforward strategy will be successful to eliminate not only existing drug shortages but more importantly avoid future risks of shortages.     Europe can rely on its the 600+ existing manufacturing sites, on its strong innovation capacity, its highly-trained workforce to reverse the trend and build back a robust pharmaceutical industry in Europe.   Industry is involved in the Commission’s EU Pharma Strategy Structured Dialogue. We are looking forward to working with the Commission to implement, as quickly as possible, the appropriate structural, pragmatic and efficient measures to support our industry.    However as we embark to build the future and drive a Renaissance of the European API and generic industry it is imperative that we first look into the past and understand what got us into this situation of dependence and weakness.    The US and Japan have already launched countermeasures, we must work with our allies and not independently.   An EU patient centric pharmaceutical industry needs a EU centric pharma supply chain with a sustainable EU manufacturing base, this requires deliberate and careful regulation to compensate for market forces and to correct the playing field.   European citizens deserve medicines that are Affordable, Accessible and most importantly Available.    Dear Commission representatives, you can count on me and on our industry associations to fill in the blanks, spend time analyzing the situation and design a solution for the future.   Thank you for your attention.   Guy Villax CEO, Hovione Lisbon, 22nd March 2021 PDF version       Find more about this virtual event at 2021portugal.eu    

News
EU Presidency: COMPET - Internal Market and Industry

Guy Villax speech to the Informal Meeting of Ministers Responsible for Competitiveness

Mar 22, 2021

This March is B Corp month – a whole month dedicated to celebrating businesses who are doing things differently and driving change and raising awareness in a globally coordinated social media effort to celebrate B Corps. In 2017, we became a Certified B Corp. Being the first Chemical/ Pharmaceutical Company integrating an innovative community of companies that use the power of business to solve social and environmental problems. Being a B Corporation means that to ensure our long‑term viability we will contribute positively to economic, environmental, and social sustainability. As a Certified B CorporationTM we want to contribute to redefine success in business, meeting the highest standards of social and environmental performance, setting our Team Members for success and personal satisfaction, and aspiring to use the power of markets to solve social and environmental problems. Collectively, B Corps lead a growing global movement of people using business as a force for goodTM. We are proud to be a B Corporation.                 Learn more about Hovione being a B Corporation      

News
We are proud to be a B Corporation.

It's B Corp Month

Mar 10, 2021

This year’s theme for International Women’s Day is #ChooseToChallenge to celebrate the achievements of women around the world. Today Hovione women also #ChooseToChallenge. From Portugal to the USA, Ireland, Macau and India, we celebrate our team’s achievements. Thank you to Beatriz Noriega Fernandes, Camie Lou, Kristen Parisi, Linda Cullinane, Louise Dennehy, Madhu Gautam, Mafalda Paiva, Marianna Katz, Marilena Ornelas, Mary Hennessy, Sarah Downing, Sarah Scott, Sónia Cardoso and Tânia Dias for raising their hands high.  From challenge comes change. Read their statements here.   O tema deste ano do Dia Internacional da Mulher é #ChooseToChallenge - Escolher Desafiar - para celebrar as conquistas das mulheres em todo o mundo. As mulheres Hovione também aderiram à campanha #ChooseToChallenge. De Portugal aos EUA, Irlanda, Macau e Índia, celebramos as conquistas da nossa equipa.   Obrigada Beatriz Noriega Fernandes, Camie Lou, Kristen Parisi, Linda Cullinane, Louise Dennehy, Madhu Gautam, Mafalda Paiva, Marianna Katz, Marilena Ornelas, Mary Hennessy, Sarah Downing, Sarah Scott, Sónia Cardoso e Tânia Dias por levantarem as vossas mãos. Do desafio vem a mudança. Leia os seus testemunhos aqui.     My name is Kristen and I’m a HR Business Partner at Hovione USA. My journey at Hovione has been one of my proudest professional achievements. I started June of 2017 in the capacity of a split role, supporting HR initiatives while maintaining office management. I have since been promoted twice and currently hold the role of HR Business Partner. Hovione provides the necessary tools and opportunities for TM’s to have a fulfilling and challenging career. O meu nome é Kristen e sou HR Business Partner na Hovione EUA. O meu trajeto na Hovione é uma das conquistas profissionais de que mais me orgulho. Comecei em junho de 2017 a apoiar iniciativas de RH enquanto mantinha a gestão do escritório. Desde então, fui promovida duas vezes e atualmente exerço a função de HR Business Partner. A Hovione fornece as ferramentas e oportunidades necessárias para que as Colaboradoras tenham uma carreira gratificante e desafiadora. Kristen Parisi - HR Business Partner Hovione USA     My name is Madhu and I’m a Director at Hovione India office. I believe in a world where everyone – regardless of their age, gender, religion, disability, sexual orientation, or ethnicity - is provided with equal opportunities and I share this belief with Hovione. To all my colleagues around the world I raise my hand: by working at Hovione we have committed ourselves to save lives and improve the quality of life of millions of patients. There is no limit to what we can do together. Be proud. Be happy! O meu nome é Madhu e sou diretora do escritório da Hovione Índia. Acredito num mundo onde todos - independentemente da sua idade, sexo, religião, incapacidade, orientação sexual ou etnia - tenham oportunidades iguais e partilho esta convicção com a Hovione. A todas as minhas colegas em todo o mundo, levanto a minha mão: ao trabalhar na Hovione, comprometemo-nos a salvar vidas e a melhorar a qualidade de vida de milhões de pacientes. Não há limite para o que podemos fazer em conjunto. Tenham orgulho. Sejam felizes! Madhu Gautam - Director of Hovione India Hovione India     My name is Camie Lou and I’m the Administrative Manager at Hovione Macau. I am proud to be part of a workplace where everyone is welcomed and so many women have the opportunity to achieve their full potential. I am challenged every day to perform my best and to all my colleagues around the world, I raise my hand: celebrate daily your personal and professional achievements. Let’s celebrate this day together! O meu nome é Camie e sou Administrative Manager na Hovione Macau. Tenho orgulho de fazer parte de uma empresa onde todos são bem-vindos e onde muitas mulheres têm a oportunidade de atingir todo o seu potencial. Sou desafiada todos os dias a dar o meu melhor e para todas as minhas colegas em qualquer parte do mundo levanto a mão: comemorem diariamente as vossas conquistas pessoais e profissionais. Vamos comemorar este dia juntas! Camie Lou - Administrative Manager Hovione Macau     At Hovione Eireann, we are very proud of our diverse and inclusive culture and love to find ways to celebrate it. One aspect of our diversity is our gender balance across our teams and at all levels of the organization and therefore we have again decided to plan an event to celebrate the annual ‘International Women's Day’ on Monday March 8th. We will host a virtual art class, during which we will design a card to send to a woman who inspires us. In keeping with this year’s theme, #choosetochallenge, we are challenging ourselves to try something new and creative, keeping in mind the importance of ensuring everyone on our teams has a voice. This year our event is in aid of Cuanlee, a women's refuge in Cork city which has seen a big increase in calls for help this year due to the lockdowns over the past 12 months. We hope our contribution towards them helps in some way with the challenges they face every day. Na Hovione Irlanda, temos muito orgulho da nossa cultura diversificada e inclusiva e adoramos encontrar formas de a celebrar. Um aspeto da nossa diversidade é o equilíbrio de género nas nossas equipas e em todos os níveis da organização e, por isso, decidimos novamente planear um evento para celebrar o ‘Dia Internacional da Mulher’ na segunda-feira, 8 de março. Faremos uma aula de arte virtual, durante a qual desenharemos um cartão para enviar a uma mulher que nos inspire. De acordo com o tema deste ano, #choosetochallenge, estamos a desafiar-nos para tentar algo novo e criativo, tendo em mente a importância de garantir que todos nas nossas equipas têm uma voz. Este ano, o nosso evento irá apoiar a Cuanlee, um refúgio feminino na cidade de Cork, que teve um grande aumento no número de pedidos de ajuda devido aos confinamentos dos últimos 12 meses. Esperamos que a nossa contribuição as possa ajudar a enfrentar os desafios de todos os dias. Mary Hennessy - Director of Human Resources Ireland Louise Dennehy - HR Business Partner, Linda Cullinane - Supply Chain Director, Sarah Downing - QA Director, Sarah Scott - Product Quality Manager Hovione Ireland     My name is Tânia and I’m an Events Coordinator at Hovione Portugal. In my professional career, I have always achieved my goals, always keeping an attitude based of humility, integrity, and an open mind! Joining Hovione was one of those goals, and it has brought me new experiences, both professionally and personally. O meu nome é Tânia e sou Events Coordinator na Hovione Portugal. No meu percurso profissional, tenho lutado sempre para concretizar as metas a que me proponho, seguindo sempre a minha visão pessoal de humildade, integridade e otimismo! A entrada na Hovione foi uma dessas metas, que me tem trazido novas experiências quer a nível profissional como pessoal. Tânia Dias - Events Coordinator Hovione Portugal     My name is Mafalda and I am a proud scientist at Hovione R&D Portugal. My journey here began six years ago, as an analytical chemist, and evolved to management positions, all within R&D. I am passionate about science, business and people! I truly believe that we can all achieve our goals and pursue our passions, if we truly work for it, independent of gender, race, sexual orientation or religion. The sky is, indeed, the limit! O meu nome é Mafalda e sou uma orgulhosa cientista na Hovione Portugal. A minha viagem começou aqui há seis anos, como analytical chemist, e evoluiu para cargos de gestão, tudo dentro da área de R&D. Sou apaixonada pela ciência, negócios e pessoas! Acredito verdadeiramente que todos podemos alcançar os nossos objetivos e seguir as nossas paixões, se realmente trabalharmos para isso, independentemente do género, raça, orientação sexual ou religião. O céu é, de facto, o limite! Mafalda Paiva - Group Leader, R&D Analytical Development Hovione Portugal     My name is Marilena and I’m an Operational Excellence Engineer at Hovione Portugal. I always thought that to practice cross fit you had to be very strong and a bit crazy. Guess what, I am one of the crazy ones, and all I needed was to step out of my comfort zone, to practice a lot and never give up. O meu nome é Marilena e sou Operational Excellence Engineer na Hovione Portugal. Sempre achei que para praticar cross fit era necessário ser uma pessoa muito forte e louca. Adivinhem, eu sou uma das loucas, e tudo o que eu precisava era sair da minha zona de conforto, praticar muito e nunca desistir. Marilena Ornelas - Operational Excellence Engineer Hovione Portugal     My name is Beatriz and I’m a scientist at Hovione Portugal. From a small town to the capital, from engineering to pharmaceutical development, I feel a sense of accomplishment knowing my everyday small tasks help to save lives. I was lucky to be born in a place where I had all the opportunities available for me, however this is still not the case for so many women all around the world. I will continue to speak up for them.  O meu nome é Beatriz e sou cientista na Hovione Portugal. De uma pequena cidade à capital, da engenharia ao desenvolvimento farmacêutico, sinto-me realizada por saber que as minhas pequenas tarefas diárias ajudam a salvar vidas. Tive a sorte de nascer com todas as oportunidades à minha espera, mas esse ainda não é o caso de muitas mulheres em todo o mundo. Por elas, continuarei a falar. Beatriz Noriega Fernandes - Scientist, R&D DPD Inhalation Hovione Portugal     My name is Sónia and I work at RDP Analytical Sciences at Hovione Portugal. I feel glad to be able to enjoy a fulfilled life by combining the things that I love most: family, science and helping others. O meu nome é Sónia e trabalho na área de RDP Analytical Sciences na Hovione Portugal. Estou feliz por ter uma vida plena ao combinar as coisas que mais amo: família, ciência e ajudar os outros. Sónia Cardoso - RDP Analytical Sciences Hovione Portugal     My name is Marianna and I'm a Scientist at Hovione Portugal. Study hard. Play the cello. Move abroad. Run a half marathon. Explore different cultures. Work hard. Do a headstand. Innovate. Have fun. Change lives. Love. Choose to challenge. The sky is the limit. Women are versatile, support and acknowledge them! O meu nome é Marianna e sou cientista na Hovione Portugal. Estuda muito. Toca violoncelo. Muda de país. Corre uma meia maratona. Explora diferentes culturas. Trabalha no duro. Pratica headstand. Inova. Diverte-te. Muda vidas. Ama. Escolhe desafiar. O céu é o limite. As mulheres são versáteis, vamos apoiá-las e reconhecê-las! Marianna Katz - Scientist – R&D Products Hovione Portugal              

News
Choose To Challenge

2021 International Women's Day - Read statements

Mar 08, 2021

Guy Villax spoke for the EU API industry at the EU Pharma Strategy Structured Dialogue that the EU Commission launched today. He said: EFCG members make Active Pharmaceutical Ingredients, the core of medicines. The EU has not been in control over its generic medicines for some time – we face frequent shortages and a geostrategic fundamental dependence on APIs and precursors from India and China – where serious accidents, government policies and market failures make us vulnerable.   We have ended up in this untenable situation due to i) unbridled market forces and globalization and ii) 30 years of EU regulations that did not consider that pharma is an intensely globalized and highly competitive industry.  Europe was once the cradle of pharmaceuticals. Today price pressure has driven the generics supply chain to prefer to buy 74% of APIs and precursors from low cost countries with limited regulation. These production locations have low regulatory oversight therefore present higher risk to patient, often cause environmental and antimicrobial resistance because of poor control over wastes, and have a high frequency of deadly accidents – EU industry cannot compete with such low cost operations.   EFCG was founded to level the playing field, this need remains. An EU patient centric pharmaceutical industry needs a EU centric pharma supply chain with a sustainable EU manufacturing base, this requires deliberate and careful regulation to compensate for market forces and to correct the playing field. The US and Japan have already launched countermeasures, we must work with our allies and not independently. European citizens deserve medicines that are Affordable, Accessible and most importantly Available. EFCG knows the issues well and is ready to help, count on us in this partnership. Pierre Luzeau will next list the needed solutions.     The meeting gathered representatives of pharma industry (generics and innovators), patients, hospital pharmacists as well as addressed Minister Marta Temido, MEPs Dolors Montserrat and Nathalie Colin–Oesterlé, Commissaires Kyriakides and Breton, Vice President Schinas.    About the Structured dialogue on Security of Medicines Supply   About EFCG    

News
Today, at the EU Pharma Strategy Structured Dialogue

Guy Villax spoke for the EU API industry

Feb 26, 2021

  3 FEBRUARY 2021 - Belem Cultural Centre - CCB, LISBON - (online event)   The Case for Sustainable Accounting Standards When the planet faces big issues, scientists are the first to flag them, the first to understand them, the first to design solutions – sadly science is seldom at the table when business decisions are taken. When the issues are simple, such as the ozone hole above Antarctica, scientists can get decision-makers to understand and act and we have Science to thank for the Montreal protocol: 20 years elapsed from discovery to inverting the trend – this speed is possible when the problem is simple: a single chemical reaction -ozone and chlorine- and a single culprit – man-made CFC gases. Climate change is very complex, there are multiple causes, the magnitude of change needed is massive and therefore cannot be solved without a transversal approach. Scientists are not able to influence decision-making because they do not speak the language of business. Companies, CEOs, asset managers, shareholders, funds march to the tune of profitability, their language is that of financial performance – today’s accounting standards ignore externalities and measure business profit not accounting for the good and the bad impacts of business on society and on the environment. Sustainable accounting standards that measure profitability adjusted for social and environmental impact is the necessary new common language if we are to ensure scientists, business and other stakeholders understand each-other. If we do not measure, we cannot manage. CFOs don’t know what is a mole of a newton, as much as most people in this room might not know what is EBITDA or an impairment. We must measure unambiguously the true and complete value of business. This measure of value added corrected for sustainability can connect to a measure of sustainable GDP of a city or of a country, which in turn can connect with the value of the world's ecosystem services and natural capital. Tracking this performance over time will allow to assess the trajectory of the health of our planet. Sustainable accounting standards will drive business to hire new skills. Finance and controlling areas will recruit scientists, engineers, anthropologists, sociologists... Over time the Chief Financial Officer will see its role evolving to that of a Chief Value Officer. If business adopts sustainable accounting standards, executives and shareholders will know the complete extent of their impact and the liabilities they face from exposure to climate change. No one can then plead ignorance. Taxation can take into account social benefits and environmental costs thereby driving desired behaviors. No amount of Science Based targets and Mission Oriented R&D projects can ever come close to the impact on Climate Change that Business harnessed by the right accounting standards can deliver by doing its day-to-day work in a manner that considers the people and the planet. Sustainable accounting standards will allow the market forces to drive decisions in the right direction. Putting a man on the moon by the decade’s end, may be more inspiring than making every company in the EU to comply with Sustainable Accounting Standards. This may come across as a small step for the EU Commission to take, but it would be a giant leap for the planet. How could Horizon Europe spur the innovations necessary not only to embrace sustainable accounting practices, but also make it possible for economic, business and investment actors to evolve the underlying logic of market capitalism to value natural, social and human capital on par with financial? Could the EU lead the world in this evolution during next 10 years?”   Guy Villax Lisbon, 3rd February 2021 PDF version       Find more about this virtual event at 2021portugal.eu  

News
EU Presidency: Informal Meeting of Ministers Responsible for Research

The Case for Sustainable Accounting Standards

Feb 03, 2021

  We are pleased to announce that the Hovione New Jersey site has been awarded the Environmental Stewardship Award by the New Jersey Department of Environmental Protection (NJDEP). The Stewardship Award from the NJDEP demonstrates the Hovione New Jersey site’s ability to go beyond minimum requirements of existing rules & regulations. This initiative is a recognition program developed by Compliance & Enforcement for use by all NJDEP programs that conduct compliance assurance inspections.   Learn more about Hovione New Jersey      

News
The New Jersey Department of Environmental Protection awarded Hovione New Jersey with the Environmental Stewardship

Hovione receives the NJDEP Environmental Stewardship Award

Jun 12, 2020

A group of Nurses thanks Hovione for donating hand sanitizer by sending us this picture. Hovione is producing hand sanitizer pro bono to help with Covid-19 prevention. Our aim is to help to prevent the shortage of hand sanitizer in Portugal especially in what concerns Health units and other official entities directly involved with the measures to contain the Covid-19 pandemic. In a moment in which we are all called to mobilize and help to reduce the impact of Covid-19, this is one way in which we are very glad to contribute.   You might be also interested in: Stepping up to the hand sanitizer shortage Covi-19: Hand sanitiser effort continues    

News
Hand sanitizer donated by Hovione

Covid-19: Group of Nurses thanks Hovione

Mar 27, 2020

March is B Corp Month. It is also the month where all B Corps are together spreading the word about this global movement of people who use business as a force for good™. All of our products/services contribute to the positive development of individual health and well-being. How? We want to contribute to redefine success in business, meeting the highest standards of social and environmental performance, setting our team members for success and personal satisfaction, and aspiring to use the power of markets to solve social and environmental problems. Collectively, B Corps lead a growing global movement of people using business as a force for goodTM. We believe that B Corps, through the power of their collective voice, are competing to be the best for the world® and through them, society will enjoy a more shared and durable prosperity. We are all in this world together and need to take responsibility towards each other. We are In it for life.   You might be interested in: Sustainability at Hovione  

News
March is B Corp Month

To be the Best for the World®

Mar 18, 2020

Contact Us

If you would like to learn more about Hovione, kindly fill in the form below and we will be revert to you soon.